Cytori Therapeutics reported $5.17M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Baxter International BAX:US USD 6.57B 3.18B
Cytori Therapeutics CYTX:US USD 5.17M 47K
Dr.Reddys Laboratories DRRD:IN INR 51.75B 4.33B
Infinity Pharmaceuticals INFI:US USD 11.59M 1.11M
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Northwest Biotherapeutics NWBO:US USD 16.28M 5.41M
Starpharma Holdings Ltd SPL:AU AUD 10.82M 330K
Sun Pharmaceuticals SUNP:IN INR 88.94B 5.3B
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B